Clinical Trial Update: Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ibrtutinib in combination with corticosteroids versus placebo with corticosteroids for new onset chronic graft-versus-host disease; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Chronic Graft Versus Host Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-05-04